CD55 and pancreatic intraductal papillary-mucinous neoplasm: As noted above, CD55 was previously reported as a biomarker for IPMN by gene expression microarray experiments and was found to be associated with disease progression in a proteomic profiling study of IPMN cyst fluid (19, 42).